284 related articles for article (PubMed ID: 26002186)
1. Morphometric and neurochemical alterations found in l-BMAA treated rats.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Martínez A; Arahuetes RM
Environ Toxicol Pharmacol; 2015 May; 39(3):1232-45. PubMed ID: 26002186
[TBL] [Abstract][Full Text] [Related]
2. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
[TBL] [Abstract][Full Text] [Related]
3. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
Banack SA; Metcalf JS; Bradley WG; Cox PA
Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
[TBL] [Abstract][Full Text] [Related]
4. Editor's Highlight: Embryonic Exposure to the Environmental Neurotoxin BMAA Negatively Impacts Early Neuronal Development and Progression of Neurodegeneration in the Sod1-G93R Zebrafish Model of Amyotrophic Lateral Sclerosis.
Powers S; Kwok S; Lovejoy E; Lavin T; Sher RB
Toxicol Sci; 2017 May; 157(1):129-140. PubMed ID: 28123103
[TBL] [Abstract][Full Text] [Related]
5. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
6. Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis.
Bradley WG
Amyotroph Lateral Scler; 2009; 10 Suppl 2():118-23. PubMed ID: 19929743
[TBL] [Abstract][Full Text] [Related]
7. Three phases of research on beta-N-methylamino-L-alanine (BMAA)--a neurotoxic amino acid.
Nunn PB
Amyotroph Lateral Scler; 2009; 10 Suppl 2():26-33. PubMed ID: 19929728
[TBL] [Abstract][Full Text] [Related]
8. Animal models of BMAA neurotoxicity: a critical review.
Karamyan VT; Speth RC
Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
[TBL] [Abstract][Full Text] [Related]
9. Linking β-methylamino-L-alanine exposure to sporadic amyotrophic lateral sclerosis in Annapolis, MD.
Field NC; Metcalf JS; Caller TA; Banack SA; Cox PA; Stommel EW
Toxicon; 2013 Aug; 70():179-83. PubMed ID: 23660330
[TBL] [Abstract][Full Text] [Related]
10. BMAA--an unusual cyanobacterial neurotoxin.
Vyas KJ; Weiss JH
Amyotroph Lateral Scler; 2009; 10 Suppl 2():50-5. PubMed ID: 19929732
[TBL] [Abstract][Full Text] [Related]
11. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
12. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
Liu X; Rush T; Zapata J; Lobner D
Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
14. Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in horses.
Brenner SR
Med Hypotheses; 2013 Jan; 80(1):103. PubMed ID: 23146671
[No Abstract] [Full Text] [Related]
15. BMAA and Neurodegenerative Illness.
Cox PA; Kostrzewa RM; Guillemin GJ
Neurotox Res; 2018 Jan; 33(1):178-183. PubMed ID: 28540663
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Long-term, Low-dose β-N-methylamino-L-alanine (BMAA) Exposures in Adult SOD
Weeks RD; Banack SA; Howell S; Thunga P; Metcalf JS; Green AJ; Cox PA; Planchart A
Neurotox Res; 2023 Oct; 41(5):481-495. PubMed ID: 37552461
[TBL] [Abstract][Full Text] [Related]
17. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.
Stommel EW; Field NC; Caller TA
Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360
[TBL] [Abstract][Full Text] [Related]
18. The cyanobacterial amino acid β-N-methylamino-l-alanine perturbs the intermediary metabolism in neonatal rats.
Engskog MK; Karlsson O; Haglöf J; Elmsjö A; Brittebo E; Arvidsson T; Pettersson C
Toxicology; 2013 Oct; 312():6-11. PubMed ID: 23886855
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal infusion of BMAA induces selective motor neuron damage and astrogliosis in the ventral horn of the spinal cord.
Yin HZ; Yu S; Hsu CI; Liu J; Acab A; Wu R; Tao A; Chiang BJ; Weiss JH
Exp Neurol; 2014 Nov; 261():1-9. PubMed ID: 24918341
[TBL] [Abstract][Full Text] [Related]
20. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.
Caller TA; Field NC; Chipman JW; Shi X; Harris BT; Stommel EW
Amyotroph Lateral Scler; 2012 Jan; 13(1):25-32. PubMed ID: 22214351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]